Artal Group’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $172M | Sell |
|
|||||
|
2021
Q2 | $176M | Hold |
|
|||||
|
2021
Q1 | $190M | Hold |
|
|||||
|
2020
Q4 | $179M | Hold |
|
|||||
|
2020
Q3 | $158M | Hold |
|
|||||
|
2020
Q2 | $133M | Sell |
|
|||||
|
2020
Q1 | $135M | Buy |
|
|||||
|
2019
Q4 | $63.6M | Sell |
|
|||||
|
2019
Q3 | $59.3M | Hold |
|
|||||
|
2019
Q2 | $61.6M | Sell |
|
|||||
|
2019
Q1 | $76.8M | Buy |
|
|||||
|
2018
Q4 | $45.7M | Buy |
|
|||||
|
2018
Q3 | $57.2M | Hold |
|
|||||
|
2018
Q2 | $48.5M | Buy |
|
|||||
|
2018
Q1 | $33.2M | Buy |
|
|||||
|
2017
Q4 | $31.8M | Buy |
|
|||||
|
2017
Q3 | $26.1M | Hold |
|
|||||
|
2017
Q2 | $21.3M | Sell |
|
|||||
|
2017
Q1 | $19.9M | Buy |
|
|||||
|
2016
Q4 | $3.83M | Sell |
|
|||||
|
2016
Q3 | $6.33M | Buy |
|
|||||
|
2016
Q2 | $3.4M | Buy |
|